FindTrial
Sign In

Study on optimal blood transport reconstruction strategy for acute STEMI

a randomized controlled trial on optimal blood transport reconstruction strategy for acute STEMI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015887
Enrollment
Unknown
Registered
2018-04-26
Start date
2015-07-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute STEMI

Interventions

1:routine PCI
2:primary PCI
3:delayed PCI

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Acute st-segment elevation myocardial infarction in patients aged 18-75 years; 2. The onset time was less than 12 hours; 3. patients were considered to have good compliance 4.Patients who have signed informed consent.

Exclusion criteria

Exclusion criteria: 1. The patient refused to sign the informed consent or was unable to undergo a CT examination after 1 year; 2. The researchers considered that the patient will be poor compliance; 3. The life expectancy of patients is <1 year; 4. Women during pregnancy; 5. Vasculopathy after coronary artery bypass grafting; 6. Allergic to antithrombotic drugs, contrast agents or stent coatings; 7. The pump failure.

Design outcomes

Primary

MeasureTime frame
No/slow blood flow rate.;occurrence rate of stent malapposition;endothelial coverage;—

Secondary

MeasureTime frame
adverse event rate;viable myocardium;—

Countries

China

Contacts

Public ContactLijiang Tang

Zhejiang Hospital

taizhoutang@hotmail.com+86 18058785203

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026